-
Product Insights
NewMucolipin 1 – Drugs In Development, 2024
The Mucolipin 1 pipeline drugs market research report outlays comprehensive information on the Mucolipin 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, Undisclosed, and Musculoskeletal Disorders which include indications of Neurodegenerative Diseases, Parkinson's Disease, Lysosomal Storage Disorder, Niemann-Pick Disease Type C, Unspecified Rare Disease, and Muscular Dystrophy. It also reviews key...
-
Product Insights
NewC-C Chemokine Receptor Type 2 – Drugs In Development, 2024
The C-C Chemokine Receptor Type 2 pipeline drugs market research report outlays comprehensive information on the C-C Chemokine Receptor Type 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Genito Urinary System, Central Nervous System, and Gastrointestinal which include indications of Colorectal Cancer, Hepatocellular Carcinoma, Focal Segmental Glomerulosclerosis (FSGS), Diabetic Nephropathy, Alzheimer's Disease, Neuropathic Pain (Neuralgia),...
-
Product Insights
NewC-C Chemokine Receptor Type 4 – Drugs In Development, 2024
The C-C Chemokine Receptor Type 4 pipeline drugs market research report outlays comprehensive information on the C-C Chemokine Receptor Type 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Dermatology, and Undisclosed which include indications of Non-Hodgkin Lymphoma, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Asthma, Allergic Asthma, Atopic Dermatitis (Atopic Eczema), Chronic Urticaria Or Hives, and...
-
Product Insights
NewC-X-C Chemokine Receptor Type 1 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 1 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Dermatology which include indications of Metastatic Colorectal Cancer, Solid Tumor, Psoriasis, Inflammation, Obesity, Type 1 Diabetes (Juvenile Diabetes), and Hidradenitis Suppurativa. It also...
-
Product Insights
NewApolipoprotein C III – Drugs In Development, 2024
The Apolipoprotein C III pipeline drugs market research report outlays comprehensive information on the Apolipoprotein C III targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Gastrointestinal, and Genetic Disorders which include indications of Hypertriglyceridemia, Familial Chylomicronemia (Type I Hyperlipoproteinemia), Hypertension, Unspecified Cardiovascular Disorders, Metabolic Dysfunction-Associated Steatohepatitis (MASH), and Hemochromatosis. It also reviews key players...
-
Product Insights
NewProtein Kinase C Epsilon Type – Drugs In Development, 2024
The Protein Kinase C Epsilon Type pipeline drugs market research report outlays comprehensive information on the Protein Kinase C Epsilon Type targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Cardiovascular, Infectious Disease, and Oncology which include indications of Traumatic Brain Injury, Amyotrophic Lateral Sclerosis, Ischemia Reperfusion Injury, Ischemic Stroke, Human Immunodeficiency Virus (HIV) Infections...
-
Product Insights
NewApolipoprotein C – Drugs In Development, 2024
The Apolipoprotein C pipeline drugs market research report outlays comprehensive information on the Apolipoprotein C targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Gastrointestinal, and Genetic Disorders which include indications of Hypertriglyceridemia, Familial Chylomicronemia (Type I Hyperlipoproteinemia), Hypertension, Unspecified Cardiovascular Disorders, Metabolic Dysfunction-Associated Steatohepatitis (MASH), and Hemochromatosis. It also reviews key players involved in...
-
Product Insights
NewCoagulation Factor XI – Drugs In Development, 2024
The Coagulation Factor XI pipeline drugs market research report outlays comprehensive information on the Coagulation Factor XI targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Hematological Disorders, Genito Urinary System, and Central Nervous System which include indications of Thrombosis, Venous Thromboembolism, Bleeding And Clotting Disorders, Hemophilia C (Factor XI Deficiency), End-Stage Kidney Disease (End-Stage Renal Disease...
-
Product Insights
NewEstrogen Receptor – Drugs In Development, 2024
The Estrogen Receptor pipeline drugs market research report outlays comprehensive information on the Estrogen Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Women's Health, Metabolic Disorders, and Central Nervous System which include indications of Breast Cancer, Metastatic Breast Cancer, Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy), Vasomotor Symptoms of Menopause (Hot Flashes), Obesity, Niemann-Pick Disease Type...
-
Product Insights
NewC-X-C Chemokine Receptor Type 4 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 4 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Infectious Disease, and Dermatology which include indications of Solid Tumor, Oncology, Transplant Rejection, Autoimmune Disorders, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.